NVAX
Novavax Inc
Price:  
15.11 
USD
Volume:  
9,974,935.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Novavax Relative Valuation

-674.1%
Upside

As of 2024-05-30, the Relative Valuation of Novavax Inc (NVAX) is (86.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.11 USD, the upside of Novavax Inc based on Relative Valuation is -674.1%.

The range of the Relative Valuation is (85.19) - (79.51) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 30.0x - 38.8x 33.6x
Forward P/E multiples 26.9x - 28.0x 27.5x
Fair Price (85.19) - (79.51) (86.75)
Upside -663.8% - -626.2% -674.1%
15.11 USD
Stock Price
(86.75) USD
Fair Price

Novavax Relative Valuation - Historical P/E Data

Date P/E
2024-05-29 -5.32
2024-05-28 -5.46
2024-05-24 -5.46
2024-05-23 -5.34
2024-05-22 -5.53
2024-05-21 -5.25
2024-05-20 -5.21
2024-05-17 -4.58
2024-05-16 -5.07
2024-05-15 -4.54
2024-05-14 -4.75
2024-05-13 -4.62
2024-05-10 -3.13
2024-05-09 -1.57
2024-05-08 -1.57
2024-05-07 -1.62
2024-05-06 -1.68
2024-05-03 -1.74
2024-05-02 -1.66
2024-05-01 -1.64
2024-04-30 -1.52
2024-04-29 -1.51
2024-04-26 -1.44
2024-04-25 -1.39
2024-04-24 -1.46
2024-04-23 -1.48
2024-04-22 -1.43
2024-04-19 -1.40
2024-04-18 -1.37
2024-04-17 -1.37
2024-04-16 -1.41
2024-04-15 -1.45
2024-04-12 -1.51
2024-04-11 -1.51
2024-04-10 -1.50
2024-04-09 -1.56
2024-04-08 -1.56
2024-04-05 -1.56
2024-04-04 -1.56
2024-04-03 -1.60
2024-04-02 -1.60
2024-04-01 -1.64
2024-03-28 -1.68
2024-03-27 -1.71
2024-03-26 -1.66
2024-03-25 -1.69
2024-03-22 -1.66
2024-03-21 -1.66
2024-03-20 -1.70
2024-03-19 -1.74